What is LAB's health score?

STANDARD BIOTOOLS INC. (LAB) has a TradeApes health score of 45 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is LAB's estimated fair value?

Based on our 5-year discounted cash flow model, STANDARD BIOTOOLS INC.'s estimated fair value is $1.19 per share, representing a 3.5% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is LAB undervalued or overvalued?

Our model currently rates LAB as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for LAB... Refresh in a moment for the full analysis.

STANDARD BIOTOOLS INC. (LAB)

Healthcare Fair Value low mixed

$1.15

Updated: 2026-05-30

TradeApes Score

Financial Strength

40 Weak

Operating Trend

40 Weak

Relative Value

50 Mixed

Capital Allocation

30 Weak

Risk

80 Strong

Est. Fair Value $1.19

DCF Upside +3.5%

Sector Rank #2751 of 6836

Key Findings

+ Low P/E — below 12×, potential value relative to earnings

Unlock Full Report →

− Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.